Annual Cash & Cash Equivalents
$64.33 M
-$11.65 M-15.33%
31 December 2023
Summary:
Kronos Bio annual cash & cash equivalents is currently $64.33 million, with the most recent change of -$11.65 million (-15.33%) on 31 December 2023. During the last 3 years, it has fallen by -$183.68 million (-74.06%). KRON annual cash & cash equivalents is now -74.06% below its all-time high of $248.01 million, reached on 31 December 2020.KRON Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$74.96 M
+$4.76 M+6.78%
30 September 2024
Summary:
Kronos Bio quarterly cash and cash equivalents is currently $74.96 million, with the most recent change of +$4.76 million (+6.78%) on 30 September 2024. Over the past year, it has increased by +$17.36 million (+30.15%). KRON quarterly cash and cash equivalents is now -69.77% below its all-time high of $248.01 million, reached on 31 December 2020.KRON Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRON Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.3% | +30.1% |
| 3 y3 years | -74.1% | -65.5% |
| 5 y5 years | +529.0% | - |
KRON Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.1% | at low | -65.5% | +68.8% |
| 5 y | 5 years | -74.1% | +529.0% | -69.8% | +130.2% |
| alltime | all time | -74.1% | +529.0% | -69.8% | +130.2% |
Kronos Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $74.96 M(+6.8%) |
| June 2024 | - | $70.21 M(+52.0%) |
| Mar 2024 | - | $46.20 M(-28.2%) |
| Dec 2023 | $64.33 M(-15.3%) | $64.33 M(+11.7%) |
| Sept 2023 | - | $57.60 M(+29.7%) |
| June 2023 | - | $44.40 M(-28.0%) |
| Mar 2023 | - | $61.65 M(-18.9%) |
| Dec 2022 | $75.97 M | $75.97 M(+12.6%) |
| Sept 2022 | - | $67.48 M(-21.7%) |
| June 2022 | - | $86.14 M(-42.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $148.98 M(-24.9%) |
| Dec 2021 | $198.27 M(-20.1%) | $198.27 M(-8.6%) |
| Sept 2021 | - | $216.99 M(+16.9%) |
| June 2021 | - | $185.66 M(+31.3%) |
| Mar 2021 | - | $141.45 M(-43.0%) |
| Dec 2020 | $248.01 M(+661.5%) | $248.01 M(+58.8%) |
| Sept 2020 | - | $156.20 M(+311.4%) |
| June 2020 | - | $37.97 M(+16.6%) |
| Dec 2019 | $32.57 M(+218.5%) | $32.57 M |
| Dec 2018 | $10.23 M | - |
FAQ
- What is Kronos Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kronos Bio?
- What is Kronos Bio annual cash & cash equivalents year-on-year change?
- What is Kronos Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kronos Bio?
- What is Kronos Bio quarterly cash and cash equivalents year-on-year change?
What is Kronos Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of KRON is $64.33 M
What is the all time high annual cash & cash equivalents for Kronos Bio?
Kronos Bio all-time high annual cash & cash equivalents is $248.01 M
What is Kronos Bio annual cash & cash equivalents year-on-year change?
Over the past year, KRON annual cash & cash equivalents has changed by -$11.65 M (-15.33%)
What is Kronos Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KRON is $74.96 M
What is the all time high quarterly cash and cash equivalents for Kronos Bio?
Kronos Bio all-time high quarterly cash and cash equivalents is $248.01 M
What is Kronos Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, KRON quarterly cash and cash equivalents has changed by +$17.36 M (+30.15%)